Therapeutic Immunomodulation
Therapeutic Immunomodulation is a targeted intervention strategy within chronic infection immunology that selectively alters immune system components or pathways to restore protective immunity or limit immunopathology, distinguishing it from broad-spectrum immunosuppression or non-specific immune activation.
164
Publications
8K
Citations
972
Authors
386
Institutions
Publications per year
2017–2026
50
Variants
Immunomodulatory Therapy
Parents
164
Mark E. Flanagan, Todd A. Blumenkopf, William H. Brissette et al. · Journal of Medicinal Chemistry · 2010 · 335 citations · Full text
Audrey Guéniche, B. Knaudt, Eduardo Schuck et al. · British Journal of Dermatology · 2008 · 244 citations
Rational design of anti-GITR-based combination immunotherapy
Roberta Zappasodi, Cynthia A. Sirard, Yanyun Li et al. · Nature Medicine · 2019 · 228 citations · Full text
1–5 of 164
972
Korea Research Institute of Standards and Science, South Korea
3 publications · 179 citations
3
h-index
3
h-index
3
h-index
3
h-index
3
h-index
1–5 of 972
386
Harvard University
Cambridge, United States
6 h-index
16 publications
866 citations

Johns Hopkins University
Baltimore, United States
5 h-index
10 publications
297 citations
Inserm
Paris, France
4 h-index
18 publications
773 citations
Memorial Sloan Kettering Cancer Center
New York, United States
4 h-index
19 publications
3.7K citations
University of Pennsylvania
Philadelphia, United States
4 h-index
15 publications
948 citations
New York University
New York, United States
4 h-index
14 publications
947 citations

Johns Hopkins Medicine
Baltimore, United States
3 h-index
4 publications
142 citations
Fujisawa City Hospital
Fujisawa, Japan
3 h-index
18 publications
480 citations
1–8 of 386
Repository · 18 publications · 343 citations
13
h-index
JAAD · 3 publications · 358 citations
3
h-index
3 publications · 80 citations
3
h-index
3 publications · 62 citations
3
h-index
2 publications · 82 citations
2
h-index
1–5